In a few hours, I’ll be speaking on a panel at the Milken Institute in the Hamptons about one of the subjects closest to my heart: longevity. Most of the sessions here are under Chatham House rules (no photos, no quotes) but what I can share is how deeply impressed I am by the focus on health innovation and longevity.
As physicians, it’s not always easy to step outside our daily practice and see the bigger picture. Yet these conversations remind me why it matters. I’m grateful for the opportunity to represent longevitydocs at the Milken Institute and to push forward our mission: democratizing longevity medicine.
In this week newsletter:
- Buzz in the Chat: What are your thoughts about doing TKA (Total Knee Arthroplasty) on a 90 year old woman?
- Cover Story: 50¢-a-Day Longevity Promise
- Research Radar: Tau biomarkers staging • Rejuvenation of Senescent Cells • COVID-19 and accelerated vascular ageing
- Longevity in the News: How ‘Optimisation’ Hijacked Men’s Wellness • The Era of Longevity Travel • 2 anti-aging pills? • Can We Beat Cancer?
- Longevity Intelligence: $199 Superpower Labs •Eight Sleep Secures $100 Million • GLP-1 drug Wegovy to treat MASH
Healthy Sunday!
Dr. David Luu
Always inspired by this view 🌊
Our team is hard at work, and I’m excited to share what’s happening behind the scenes across the longevitydocs ecosystem.
- Education: our Longevity Medicine Certification is moving forward with the CME process through ACCME accreditation. Unit 7 is now live.
- Our Upcoming Events: Peptides Mastermind, NYC, October 4 AI Mastermind, NYC, February 17, 2026 (this will be fun!)
- Members: we’re planning a longevitydocs Tour in Miami, LA, and SF by year’s end - we believe in every physician a chance to connect in person.
- Concierge: we’ve begun connecting patients directly with longevitydocs physicians.
- On Stage: proud to share the longevitydocs mission at some of the world’s leading platforms: Milken Institute, Hamptons, August 22–24 Vibrant Summit, Austin, September 24–27 Zenos Summit, Saudi Arabia, October 23–25
- Website: we’re rebuilding the longevitydocs website into the destination for longevity medicine: news, events, and a membership platform. A major relaunch is coming this September.
If you have questions or want to support the mission, I’d love to hear from you.
Each week, I try to explore one idea that could advance longevity medicine and hopefully support physicians in bringing it to life.
A VC-backed startup has launched a $199-per-year membership that promises to detect “over 1,000+ preventable conditions” through annual lab testing. Marketed as a budget version of Function Health, the pitch is seductive: for less than fifty cents a day, you can track your heart, hormones, and more.
5 reasons to be optimistic
- Simplified access: navigating prescriptions and doctor’s orders for labs can be frustrating; branding and user experience can improve the experience.
- Early alerts for healthy people: for those without obvious symptoms, $199 is a low-friction way to track biomarkers and catch issues before they manifest.
- AI is accelerating: algorithms are rapidly improving at interpreting lab data, offering faster, scalable insights than human review alone.
- Integration potential: combined with wearables and personal history, lab data could unlock genuinely personalized recommendations.
- Democratizing access: if refined, services like this could make preventive health more affordable and accessible than traditional concierge care.
5 reasons to be skeptical
- Labs ≠ medicine: bloodwork alone, without context or physician oversight, is not good medical care.
- Generic advice is free: “Eat better, move more, sleep well” doesn’t require a $199 panel.
- Liability gap: what happens if you discover sky-high cholesterol? Those companies don’t treat, because they’re not a healthcare company. That means they carry no medical liability, leaving you to find a doctor on your own.
- You can get those labs for free: the same tests are typically covered by insurance when ordered through your doctor. Online you’re paying $199 just for the booking.
- Behavior change is what matters: every provider knows labs don’t change habits. At best, a 100-test report is just a wake-up call.
My POV: We’re still in the early days of consumer AI in health, it is promising, but incomplete. Without physician integration, these platforms risk hijacking medicine rather than advancing it. The truth is, healthcare providers have left a vacuum: ordering labs, getting results, and writing prescriptions is often slow, expensive, and inaccessible. Nature hates emptiness, and startups are rushing to fill the gap. Of course it’s a huge market opportunity. But real scale and lasting impact will only come through systemic change that integrates providers, insurers, and health systems. Physicians have a choice: step up, partner, compete, or lose market share. The key is to stay educated, connected, and ahead of the curve.
At longevitydocs, we believe longevity medicine is serious medicine. Prevention, interpretation, and treatment must move together guided by trusted physicians and supported by a full ecosystem of companies, investors, regulators, and health systems.
Longevity Medicine can not be discounted. Yet it should be accessible to all.
This is unfiltered look at the most engaging conversations happening in our longevitydocs WhatsApp group.
Originally published in The Longevity Medicine Intelligence newsletter (Issue 59).
